CLINICAL_TRIALS
trial_result
· 2016-10-14
Clinical Trial Update: A Non-Comparative Study to Assess the Safety of MabThera (Rituximab) in Patients With Rheumatoid Arthritis. [Phase 3]
Summary
Phase 3 non-comparative safety study of MabThera (rituximab) in patients with rheumatoid arthritis completed; results were posted on 2016-10-14.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Hoffmann-La Roche | Conditions: Rheumatoid Arthritis | Phase 3 | Status: COMPLETED | Results posted: 2016-10-14